Waltham, Mass., USA - December 7, 2015, Waltham, Mass., USA - Forum Pharmaceuticals, a biopharmaceutical company, announced the appointment of George Parker as chief human resources officer.
Article continues below
Mr. Parker will be a member of the Company’s executive committee. He has more than 25 years of broad human resources experience in life science and pharmaceutical companies.
Mr. Parker most recently served as Vice President, Global Human Resources at Molecular Devices, a life sciences operating company of Danaher Corporation. He was previously Vice President, Human Resources at Cyberonics and PerkinElmer Instruments.
Prior to that, Mr. Parker held positions of increasing responsibility at Bayer Pharmaceuticals and Bayer Corporation. Earlier in his career, Mr. Parker was a compensation consultant at KPMG. He holds a B.A. in mathematics from Hobart College.
Forum also announced the appointments of Stephen Brannan as Vice President Clinical Research and Medical Affairs; Diana Hughes as Vice President, Pharmacovigilance and Medical Risk Management; Robert Pintar as Vice President, Supply Chain Operations; and A.J. Sankoh as Vice President, Biostatistics and Statistical Programming.
Dr. Brannan has more than 15 years industry experience in clinical and medicals affairs, preceded by 10 years of clinical psychiatric practice. He held roles of increasing responsibility at Takeda, where he was most recently Vice President CNS Clinical Science/PDD Global Therapeutic Area Head, with responsibility for the Depression Programs and other CNS projects.
Prior to Takeda, Dr. Brannan held positions of increasing responsibility at Novartis, Cyberonics and Eli Lily. He holds an M.D. degree from the University of Texas Health Science Center at Dallas (Southwestern Medical School).
Dr. Hughes brings more than 13 years of extensive pharmaceutical industry experience to FORUM. She was most recently Vice President, Worldwide Safety and Regulatory at Pfizer, where she led an enhanced global labeling initiative.
Prior to that at Pfizer, Dr. Hughes was Vice President, Worldwide Safety and Regulatory Primary Care Business Unit Lead. Earlier in her career she held positions of increasing responsibility at Pfizer in Pharmacovigilance and Risk Management Strategy. She holds a Medical Degree from London University.
Mr. Pintar has more than 25 years of experience in the biotechnology and pharmaceutical industry for both large and small companies. Most recently he was Vice President, Supply Chain for Cubist Pharmaceuticals.
Mr. Pintar held roles of increasing responsibility in supply chain and materials management at several companies, including Sandoz/Novartis, Baxter BioScience and Sanofi Pasteur. He holds an M.B.A. from the University of Scranton.
Dr. Sankoh has more than 20 years of extensive experience in the biopharmaceutical industry. Most recently he was Vice President, Biostatistics & Clinical Informatics at Synageva Biopharma.
Previously, Dr. Sankoh held leadership roles at Vertex Pharmaceuticals, sanofi-aventis and Genetics Institute/Wyeth Pharmaceuticals. ■